Boron Neutron Capture Therapy is a very promising form of cancer therapy, consisting in irradiating a stable isotope of boron ( 10 B) concentrated in tumor cells with a low energy neutron beam. This technique makes it possible to destroy tumor cells, leaving healthy tissues practically unaffected. In order to carry out the therapy in the proper way, the proper range of the neutron beam energy has to be chosen.
Introduction
BNCT (Boron Neutron Capture Therapy) is a form of radiotherapy that held promise of being beneficial to cancer patients with glioma, a type of brain cancer. This type of tumor is quite resistant to other treatment modalities and the prospects of its cure are very poor.
An ideal therapy for cancer would be one whereby all tumor cells were selectively destroyed without damaging normal tissues.
BNCT brings together two components that, when kept separate, have only minor effects on cells. The first component is a stable isotope of boron (boron-10) that can be DRAFT concentrated in tumor cells by being attached to tumor-seeking compounds. The second one is a beam of low-energy neutrons. Boron-10 in or adjacent to tumor cells disintegrates after capturing a neutron. The high-energy, heavy charged particles, produced in the nuclear reaction, destroy only the cells in close proximity to the vertex, which are primarily cancer cells, leaving adjacent normal cells largely unaffected. 4. The boron dose from 10 B absorbing a thermal neutron in a 10 B(n,a) 7 Li reaction. The emitted a particle and the recoil ion 7 Li result in locally deposited energy, of about 2.34 MeV in average. In 94% of the reactions the 7 Li ion is produced in an excited state and de-excites emitting a 477 keV gamma ray. In the remaining 6% of events, 7 Li ion is emitted in the ground state.
In our previous publication [1] we have calculated selected dose components in a human head model using MCNP code. The components taken into account were: -the gamma ray dose component, -the nitrogen dose component, -the boron dose component.
The calculations were made for monoenergetic neutron beams, in the energy range between 1 eV and 1 MeV, in order to choose the optimum energy range for BNCT, where the therapeutic to the injuring dose ratio is the highest.
The results obtained for the components above mentioned dose component didn't let us choose the optimal energy range, due to the similar dependence of cross-section on energy for 14 N(n,p) 14 C (the main component of the injuring dose) and 10 B(n,a) 7 Li (therapeutic) reactions. For more complete picture we took into account the dose component coming from epithermal and fast neutrons generating 'knock-out' recoil protons from hydrogen in tissue. 
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Method
The model of the head was defined within the code as a 20 cm diameter sphere of tissue-like material (ICRU brain) consisting of hydrogen (10.7%), carbon (14.5%), nitrogen (2.2%), oxygen (71.2%), sodium (0.2%), phosphorus (0.4%), sulfur (0.2%), chlorine (0.3%) and potassium (0.3%) of the density of 1.04 g/cm 3 . The sphere was divided into 60 pieces of various size: 6 layers of concentric, cylindrical cells up to the depth of 7 cm, and the rest of the head was defined as one cell (Figure 1 ). with the assumption that the proton is stopped within the cell where it was produced, so the kerma value equals the absorbed dose. The range of 1 MeV protons in tissue is 2.27 · 10 3 g/cm 2 [3] , for the tissue density of 1.04 g/cm 3 it equals to about 2 · 10 3 cm and it's two orders of magnitude smaller than the MCNP cell dimensions. The range for lower proton energies is even smaller, so such an assumption is justified.
Results and discussion
Comparing to the distributions of the other dose components the spatial distribution is more flat when the dependence on the beam energy is very strong. 
Conclusions
Taking into consideration the results obtained in our calculations we expect, that the best energy range for the boron neutron capture therapy is about 1 keV, due to the boron dose maximum in the most desired spot and the high therapeutic to injured ratio value.
The result is in good agreement with the literature. The results will be used to design BNCT post at the Swierk reactor.
